Literature DB >> 16896645

The high scrotal ("gliding") testis revised.

Wilfried W M Hack1, Karlijn Sijstermans, Laszla M van der Voort-Doedens, Rob W Meijer, Krijn Haasnoot.   

Abstract

BACKGROUND: At present, the high scrotal testis is considered a distinct and separate entity of undescended testis.
OBJECTIVES: The aim of this study was to assess whether high scrotal testis is actually either a congenital- or acquired-undescended testis. DISCUSSION: In 527 consecutive boys (aged 0.4 to 16.5 years, mean 7.5) referred for non-scrotal testis, the number of high scrotal testis was prospectively determined. According to previous testis position, the high scrotal testis was classified into congenital- and acquired-high scrotal testis. In congenital-high scrotal testis orchidopexy was performed whereas spontaneous descent at puberty was awaited in acquired-high scrotal testis. In 210 testes, the gonad was diagnosed as high scrotal. In six testes the condition was congenital and 204 testes were diagnosed as acquired. All cases of congenital-high scrotal testis were treated surgically. In 100 acquired-high scrotal testis follow-up was performed. Of these, 75 testes descended spontaneously at puberty.
CONCLUSION: We propose that the high scrotal testis should be regarded, not as a distinct and separate entity, but as a part of the spectrum of either congenital-undescended testis or acquired-undescended testis. Since spontaneous descent can occur at puberty in acquired-high scrotal testis, therapy may be different between both forms.

Entities:  

Mesh:

Year:  2006        PMID: 16896645     DOI: 10.1007/s00431-006-0202-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  The diagnosis of undescended testes.

Authors:  G G Wyllie
Journal:  Med J Aust       Date:  1978-06-17       Impact factor: 7.738

2.  [Retractile testis and gliding testis. Two distinct clinical entities].

Authors:  F Ferro; A Lais; E Matarazzo; N Capozza; P Caione
Journal:  Minerva Urol Nefrol       Date:  1996-09       Impact factor: 3.720

3.  Incomplete disappearance of the processus vaginalis as a cause of ascending testis.

Authors:  T D Clarnette; D Rowe; S Hasthorpe; J M Hutson
Journal:  J Urol       Date:  1997-05       Impact factor: 7.450

4.  The relationship between cerebral palsy and cryptorchidism.

Authors:  J A Smith; J M Hutson; S W Beasley; D S Reddihough
Journal:  J Pediatr Surg       Date:  1989-12       Impact factor: 2.545

5.  The retractile testis.

Authors:  W Van Essen
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

6.  The retractile testis.

Authors:  G G Wyllie
Journal:  Med J Aust       Date:  1984-03-31       Impact factor: 7.738

7.  The retractile testis: time for a reappraisal.

Authors:  D W Goh; J M Hutson
Journal:  J Paediatr Child Health       Date:  1993-12       Impact factor: 1.954

8.  The gliding testis: minor degree of true undescended testis?

Authors:  A Lais; S Caterino; M Talamo; A Nahom; P Bagolan; F Ferro
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

9.  Assent to ascent of the testis.

Authors:  J F Robertson; A F Azmy; W Cochran
Journal:  Br J Urol       Date:  1988-02

10.  Boys with late descending testes: the source of patients with "retractile" testes undergoing orchidopexy?

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27
View more
  3 in total

Review 1.  Cryptorchidism: A practical review for all community healthcare providers.

Authors:  Luis H Braga; Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Clinical aspects of histological and hormonal parameters in boys with cryptorchidism: Thesis for PhD degree.

Authors:  Simone Engmann Hildorf
Journal:  APMIS       Date:  2022-07       Impact factor: 3.428

3.  Comprehension and Practice Patterns of Korean Urologists for Retractile and Gliding Testes.

Authors:  Jae Yeon Kim; Jae Min Chung
Journal:  J Korean Med Sci       Date:  2022-03-28       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.